GIM
IRWD icon

Granahan Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Granahan Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-472,315
Closed -$4.1M – 196
2018
Q4 		$4.1M Sell
472,315
-11,522
-2% -$132K 0.29% 87
2018
Q3 		$7.48M Sell
483,837
-138,103
-22% -$2.18M 0.41% 78
2018
Q2 		$9.96M Buy
621,940
+77,357
+14% +$1.14M 0.6% 54
2018
Q1 		$7.04M Buy
544,583
+77,490
+17% +$966K 0.51% 67
2017
Q4 		$5.86M Sell
467,093
-53,491
-10% -$699K 0.46% 76
2017
Q3 		$6.88M Buy
520,584
+102,569
+25% +$1.41M 0.57% 66
2017
Q2 		$6.61M Sell
418,015
-13
-0% -$189 0.61% 57
2017
Q1 		$5.97M Sell
418,028
-1,263,124
-75% -$17.3M 0.6% 62
2016
Q4 		$21.5M Hold
1,681,152
– – 0.74% 44
2016
Q3 		$22.4M Buy
1,681,152
+333,126
+25% +$3.89M 0.73% 43
2016
Q2 		$14.8M Buy
+1,348,026
New +$13.2M 0.54% 73
2015
Q2 		– Sell
-275,575
Closed -$3.69M – 238
2015
Q1 		$3.69M Buy
+275,575
New +$3.62M 0.11% 190

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Granahan Investment Management's IRWD Position: Q1 2019 in Review

Granahan Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2019, closing a stake of 472,315 shares — an estimated $4.1M sold.

Granahan Investment Management first reported a position in IRWD in Q1 2015 and held it in 12 quarters. The position peaked at $22.4M in Q3 2016. 156 funds tracked by Wall St. Rank hold IRWD as of Q1 2019.

  • Granahan Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Granahan Investment Management sold 472,315 Ironwood Pharmaceuticals shares in Q1 2019, an estimated $4.1M.
  • Granahan Investment Management first reported a position in Ironwood Pharmaceuticals in Q1 2015 and held it in 12 quarters.
  • Granahan Investment Management's Ironwood Pharmaceuticals position peaked at $22.4M in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2019.

Based on Granahan Investment Management's 13F filing for Q1 2019, filed 14 May 2019.